Ampio Pharma (AMPE) Announces Three Peer-Reviewed Ampion Publications on Knee Osteoarthritis

June 9, 2015 8:33 AM EDT Send to a Friend
Ampio Pharma (NYSE: AMPE) announced three peer-review publications that report the multifaceted and synergistic effects of Ampion™ in the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login